Back to search

Article

RAS mutations that have a major impact on current cancer genomic medicine

2022-09-16

Abstract excerpt

The status of rat sarcoma viral oncogene homolog (RAS) proteins is a negative predictive biomarker for anti-epidermal growth factor receptor (EGFR) therapy in metastatic colon cancer. In the phase 2 CHRONOS trial, patients with mutant gene(s) are ineligible for anti-EGFR therapy. However, our studies revealed that splicing caused by the RAS mutations, which were considered oncogenic, generates unfunctional RAS fam...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5c91fbc8-ee2d-5ed9-b09d-cffdab07c635
DOI
10.32388/jwnw97
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
RAS mutations that have a major impact on current cancer genomic medicineDOI 10.32388/jwnw97
Select a neighboring publication to make it the new centre.